In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alaris Medical Inc.

Division of Cardinal Health Inc.

Latest From Alaris Medical Inc.

NuVasive Appoints Joan Stafslien General Counsel

Spine firm NuVasive named Joan Stafslien, previously with CareFusion, as general counsel.

United States Appointments

Value Proposition Is Key to New Product Success in a Cost-Conscious Medtech Market

The need for a positive economic argument when introducing a new medtech product is more critical than ever. Management teams are well aware of the need to demonstrate compelling economic data, but can a product still be successful without an economic benefit in the increasingly cost-conscious health care marketplace? Overcoming negative economics means identifying a combination of positive attributes that can overcome the economic barrier, and this thought process should be conducted well before significant R&D funds are invested.
Medical Device

Deal Statistics Quarterly, Q3 2003

In Vivo presents another installment of our quarterly reivew of dealmaking--in this case July-September 2003. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.
BioPharmaceutical Medical Device

Top Ten Pitfalls to New Medical Device Launches

It is not uncommon for a new medical device to fail to initially live up to projected sales expectations. Early disappointing product sales can produce a hole that a company can spend a long time trying to dig its way out of, having to battle a declining stock price, decreased investor confidence, lower company valuations, and diminished access to capital. The end result may be that both the product and the company are never able to fully recover from the early set-back. Many initial disappointing product roll-outs can be attributed to problems that commonly confront device companies. Product companies have adopted successful strategies to anticipate and overcome many of these issues, and thereby increase the chances of a new product coming strong out-of-the blocks.
Medical Device Reimbursement
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ivac Corp.
  • Advanced Medical Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cardinal Health Inc.
  • Senior Management
  • David L Schlotterbeck, Pres. & CEO
    William C Bopp, SVP & CFO
    Anthony B Semedo, VP, Corp. Dev.
    Kevin Whiteley, VP, Mktg.
  • Contact Info
  • Alaris Medical Inc.
    Phone: (619) 458-7000
    10221 Wateridge Circle
    San Diego, CA 92121-2733
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register